Veeva Systems is a mission-driven organization and pioneer in industry cloud, helping life sciences companies bring therapies to patients faster. As one of the fastest-growing SaaS companies in history, we surpassed $3B in revenue in our last
Department:607000 Regulatory - TTSG Location:Rapperswil-Jona (SG), Switzerland Be a part of a global team that is inspired to make a difference in the lives of people living with rare disease. At Travere Therapeutics, we recognize that
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Founded in 1921 and headquartered in Mendrisio (Switzerland), Sinteticas mission is to continuously strive to improve therapies by enhancing its products formulations and usability for the benefit of clinicians and patients. We do so in close
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Global Quality Manager (m/f/d) – Quality Assurance / GMP / GDP / Pharma / English Project: For our customer a big pharmaceutical company in Basel we are looking for a highly qualified Global Quality Manager (m/f/d)
Travere Therapeutics in Switzerland is hiring a Senior Specialist, Regulatory Affairs (EU/RoW) to support the preparation, submission and maintenance of regulatory applications, including CTA submissions and post-authorization activities.You will work with regulatory leads, coordinate with external
Department: Regulatory - TTSG Location: Rapperswil-Jona (SG), SwitzerlandBe a part of a global team that is inspired to make a difference in the lives of people living with rare disease. At Travere Therapeutics, we recognize that
Eraneos is an international strategy, transformation and technology consulting group, dedicated to empowering organizations to thrive in an ever-changing digital age. By bringing together top-tier experts from business and tech, we help clients to continuously raise
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)